Kyntra Bio, Inc. (KYNB)
7.88
-0.13
(-1.62%)
USD |
NASDAQ |
Jan 30, 16:00
7.935
+0.06
(+0.70%)
After-Hours: 20:00
Kyntra Bio Market Cap : 31.85M for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 75.59M |
| Perspective Therapeutics, Inc. | 281.74M |
| Skye Bioscience, Inc. | 32.38M |
| Theravance Biopharma, Inc. | 959.74M |
| Myomo, Inc. | 32.25M |
Market Cap Related Metrics
| PE Ratio | 0.2003 |
| PS Ratio | 26.84 |
| Price | 7.88 |
| Earnings Yield | 499.2% |
| Normalized PE Ratio | 0.1936 |